On March 20, 2023, Aimed Alliance released a new fact sheet titled “Alternative Funding Programs: The Cost Sharing Program That…
In 2022, Aimed Alliance recognized that health disparities exist in the inflammatory bowel disease (“IBD”) patient population. With rates of…
Press Release – July 6, 2022 (Albany, New York) – Over thirty patient advocacy and health policy organizations applaud the…
Aimed Alliance’s staff attorney, Ashira Vantrees, spoke with the Patient Empowerment Network for their May 2022 Activity Guide on “How…
On September 30, 2021, the Department of Health and Human Services (HHS), the Department of Labor (DOL), the Department of Treasury,…
On August 31, 2021, the Alliance for Mental Health Care Access (“AMHCA”) conducted its first roundtable meeting. AMHCA is a…
On September 1, 2021, Aimed Alliance submitted a comment to Senators Schumer, Wyden, and Booker on the Discussion Draft: Cannabis Administration and Opportunity Act…
Policymakers Should Oppose Efforts to Mandate Coverage of Non-FDA-Approved Cannabis Products that Conflict with Federal Laws & Increase Risk of…
On May 25, 2021, Aimed Alliance and 19 other patient advocacy groups and health professional organizations sent a letter to…
On May 10, 2021, Aimed Alliance sent a letter to Pennsylvania legislators in support of HB 225 and SB 225.…